• Medientyp: E-Artikel
  • Titel: Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA
  • Beteiligte: Hemmelder, Marc H; Noordzij, Marlies; Vart, Priya; Hilbrands, Luuk B; Jager, Kitty J; Abrahams, Alferso C; Arroyo, David; Battaglia, Yuri; Ekart, Robert; Mallamaci, Francesca; Malloney, Sharon-Rose; Oliveira, Joao; Rydzewski, Andrzej; Sridharan, Sivakumar; Vogt, Liffert; Duivenvoorden, Raphaël; Gansevoort, Ron T; Franssen, Casper F M; van der Net, Jeroen B; Essig, Marie; du Buf-Vereijken, Peggy W G; van Ginneken, Betty; Maas, Nanda; van Jaarsveld, Brigit C; [...]
  • Erschienen: Oxford University Press (OUP), 2022
  • Erschienen in: Nephrology Dialysis Transplantation
  • Sprache: Englisch
  • DOI: 10.1093/ndt/gfac008
  • ISSN: 0931-0509; 1460-2385
  • Schlagwörter: Transplantation ; Nephrology
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>ABSTRACT</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>Coronavirus disease 2019 (COVID-19)-related short-term mortality is high in dialysis patients, but longer-term outcomes are largely unknown. We therefore assessed patient recovery in a large cohort of dialysis patients 3 months after their COVID-19 diagnosis.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>We analyzed data on dialysis patients diagnosed with COVID-19 from 1 February 2020 to 31 March 2021 from the European Renal Association COVID-19 Database (ERACODA). The outcomes studied were patient survival, residence and functional and mental health status (estimated by their treating physician) 3 months after COVID-19 diagnosis. Complete follow-up data were available for 854 surviving patients. Patient characteristics associated with recovery were analyzed using logistic regression.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>In 2449 hemodialysis patients (mean ± SD age 67.5 ± 14.4 years, 62% male), survival probabilities at 3 months after COVID-19 diagnosis were 90% for nonhospitalized patients (n = 1087), 73% for patients admitted to the hospital but not to an intensive care unit (ICU) (n = 1165) and 40% for those admitted to an ICU (n = 197). Patient survival hardly decreased between 28 days and 3 months after COVID-19 diagnosis. At 3 months, 87% functioned at their pre-existent functional and 94% at their pre-existent mental level. Only few of the surviving patients were still admitted to the hospital (0.8–6.3%) or a nursing home (∼5%). A higher age and frailty score at presentation and ICU admission were associated with worse functional outcome.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>Mortality between 28 days and 3 months after COVID-19 diagnosis was low and the majority of patients who survived COVID-19 recovered to their pre-existent functional and mental health level at 3 months after diagnosis.</jats:p> </jats:sec>
  • Zugangsstatus: Freier Zugang